Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine in Persistent Allergic Rhinitis
NCT00405964Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desloratadine in persistent allergic rhinitis (PAR), sponsored by Organon & Co.. Started Sep 2006; status: completed.
02
Drugs
desloratadine
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00405964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405964.